- (Adnkronos) – Collaboration focused on novel target discovery in prostate cancer LONDON and BELLINZONA, Switzerland, Nov. 30, 2023 /PRNewswire/ — Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), and The Institute of Oncology Research (IOR) today announced the commencement of a collaborative sponsored research agreement in prostate cancer. The collaboration will focus on the identification and progression of novel targets in oncology using translational models to develop